Skip to content

4Accepted Sep 8, 4:30 PM ET

Phathom (PHAT) Robert Breedlove Surrenders 460 Shares for Tax Withholding

PHATPhathom Pharmaceuticals, Inc.

Accepted (ET)

4:30 PM

Sep 8, 2026

Filed

Sep 8, 2026

Documents

1

Size

5.6 KB

Summary

Phathom (PHAT) Robert Breedlove Surrenders 460 Shares for Tax Withholding

Updated

What Happened

  • Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals (PHAT), surrendered 460 shares underlying restricted stock units to satisfy the issuer’s tax withholding obligation. The shares were valued at $9.05 each, totaling $4,163. This was a tax-withholding disposition rather than an open-market sale.

Key Details

  • Transaction date: 2026-09-03 (report filed 2026-09-08)
  • Price per share: $9.05; shares surrendered/disposed: 460; total value: $4,163
  • Shares owned after transaction: not specified in the provided filing
  • Footnote: F1 indicates these were RSU shares surrendered to the issuer to satisfy tax withholding
  • Filing timeliness: transaction reported on a Form 4 filed Sep 8 for a Sep 3 transaction (no late-filing flag provided in the supplied data)

Context

  • This was a common cashless/tax-withholding action where an insider surrenders vested RSU shares to cover taxes; it is routine and does not necessarily reflect a view on the company’s prospects. It is different from an open-market sale, which would represent a transfer of shares to other investors.

AI-written summary · check the filing